ATRC
AtriCure, Inc.NASDAQHealthcare$29.07+2.68%ClosedMarket Cap: $1.45B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.85
P/S
2.72
EV/EBITDA
117.10
DCF Value
$-2.72
FCF Yield
3.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
74.8%
Operating Margin
-1.6%
Net Margin
-2.1%
ROE
-2.4%
ROA
-1.8%
ROIC
-1.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $140.5M | 74.4% | $3.5M | $1.8M | $0.04 | — |
| FY 2025 | $534.5M | 74.4% | $-3.4M | $-11.4M | $-0.24 | — |
| Q3 2025 | $134.3M | 75.5% | $208.0K | $-267.0K | $-0.01 | — |
| Q2 2025 | $136.1M | 74.5% | $-6.2M | $-6.2M | $-0.13 | — |
| Q1 2025 | $123.6M | 74.9% | $-6.0M | $-6.7M | $-0.14 | — |
| Q4 2024 | $124.3M | 74.5% | $-14.5M | $-15.6M | $-0.33 | — |
| FY 2024 | $465.3M | 74.7% | $-40.0M | $-44.7M | $-0.95 | — |
| Q3 2024 | $115.9M | 74.9% | $-7.4M | $-7.9M | $-0.17 | — |
| Q2 2024 | $116.3M | 74.0% | $-7.2M | $-8.0M | $-0.17 | — |
| Q1 2024 | $108.9M | 74.0% | $-10.9M | $-13.3M | $-0.28 | — |
| Q4 2023 | $106.5M | 74.2% | $-8.7M | $-9.8M | $-0.21 | — |
| FY 2023 | $399.2M | 75.2% | $-26.7M | $-30.4M | $-0.66 | — |